Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5671829 | Clinical Microbiology and Infection | 2017 | 31 Pages |
Abstract
The present study provides robust evidence indicating that in combination with the altered PBP3, the slowed drug influx and its enhanced efflux due to the loss of regulation led to the development of imipenem heteroresistance in NTHi.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
A. Cherkaoui, S.M. Diene, A. Renzoni, S. Emonet, G. Renzi, P. François, J. Schrenzel,